Age: 79.0
Sex: M
Vaccine: PNC13
Symptoms: Pulmonary function test abnormal, Respiratory disorder, Tremor
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for himself. A 79 year-old  male patient received PREVNAR 13 (lot L62075, expiry date Dec2016), via an unspecified route of administration in the right arm, on 31Jul2015 between 08:30 and 09:00 AM, at 0.5 ml single for immunisation. The patien's medical history included chronic obstructive pulmonary disease (COPD) from 28Mar2015 and ongoing, indigestion, blood pressure abnormal, cholesterol and prostatic disorder. Concomitant medications included omeprazole (20 mg capsule, unspecified trade name) from an unspecified date 30 years before this report and ongoing, at 40 mg daily (in the morning), for indigestion; amlodipine (unspecified trade name, tablet), at 5 mg 1x/day, from a long time and ongoing, for blood pressure abnormal; lisinopril (unspecified trade name, 40 mg tablet), from a long time to an unspecified date, at 60 mg daily (one and one half tablet daily), for blood cholesterol abnormal; finasteride (5 mg tablet, unspecified trade name) from a long time ago and ongoing, at 5 mg 1x/day, for prostatic disorder, atorvastatin calcium (10 mg tablet, unspecified trade name) from a long time ago and ongoing, at 10 mg 1x/day, terazosin hcl 2 mg capsule, oral mometasone furoate (ASMANEX) at 220 mcg, olodaterol hydrochloride, tiotropium bromide (STIOLTO RESPIMAT) ongoing, trazodone hcl (100 mg tablet), freestyle glucose test strip, fluocinonide 0.05 percent ointment, oral salbutamol (ALBUTEROL HFA) ongoing, losartan potassium (100 mg tablet), clonazepam at 1 mg, aminobenzoic acid, biotin, choline bitartrate, folic acid, inositol, lecithin, vitamin b nos (B 100), melatonin, magnesium, melatonin, tryptophan, l (ALTERIL), diphenhydramine hydrochloride (SLEEP AID). The patient previously received for immunisation a pneumococcal vaccine (unspecified trade name), on 03Aug2011, tetanus vaccine, diphtheria vaccine (TD) in Nov2003 and a tetanus toxoid on 01Oct2001 with no adverse effect and glimepiride (GLIPIRIDE), for diabetes mellitus, and experienced blood glucose abnormal (his readings were under 130). The patient experienced breathing issues from Aug2015 with outcome of not recovered for which received treatment, sleeping issues/trouble sleeping from Aug2015 with outcome of not recovered for which received treatment, bowel movements changed from Sep2015 with outcome of not recovered, muscle cramps from Aug2015 with outcome of not recovered, headache from Aug2015 with outcome of not recovered for which received treatment, coughing up phlegm from Aug2015 with outcome of not recovered, body tremors from Sep2015 with outcome of not recovered, disorientated from Aug2015 with outcome of recovered in Aug2015, tired on an unspecified date with outcome of not recovered. In the patient's opinion breathing issues required emergency room or doctor visit but this visit was not performed yet. The patient had undergone laboratory tests on 24Jul2015 which had included microalbumin in urine at 1.5 mg/dl (normal range: 0.0-3.0), prostate antigen in serum at 0.7 ng/ml (normal 0.1-4.0) and hepatic function panel at 1.4 (normal range 0.8-2.0). On 28Mar2016 breathing test was performed and showed an obstruction. Follow-up (14Sep2016): New information reported from the same contactable consumer includes: suspect vaccine details (lot and expiry date), further details on concomitant medications and past vaccines, reaction data (outcome of events headache and tired was changed from unknown to not recovered), laboratory data.